Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2021

Pharma News, 2021

FDA Approves Tibsovo for Adjuvant Treatment of IDH1-Mutated UC
FDA Approves Tibsovo for Adjuvant Treatment of IDH1-Mutated UC
The FDA approved ivosidenib (Tibsovo, Servier) for adults with previously treated, locally advanced or metastatic cholangiocarcinoma with an isocitrate dehydrogenase-1 (IDH1) mutation ...
UCB Announces Briviact (brivaracetam) Now FDA-Approved to Treat Partial-Onset Seizures in Pediatric Patients One Month of Age and Older
UCB Announces Briviact (brivaracetam) Now FDA-Approved to Treat Partial-Onset Seizures in Pediatric Patients One Month of Age and Older
ATLANTA, Aug.
A drug costing less than €2 a day helps in the treatment of severely ill COVID-19 patients
A drug costing less than €2 a day helps in the treatment of severely ill COVID-19 patients
Metoprolol, a drug widely used to treat cardiovascular disease, is beneficial when administered to COVID-19patients.
China CDC experts suggest survey on cold-chain suppliers to Wuhan in WHO’s 2nd-phase probe on virus origins
China CDC experts suggest survey on cold-chain suppliers to Wuhan in WHO’s 2nd-phase probe on virus origins
Amid the consensus among worldwide scientists that the second phase of the study on coronavirus origins should be carried out in multiple places, officials and experts from the Chinese Center for Dise...
Roche withdraws US approval for Tecentriq in mTNBC
Roche withdraws US approval for Tecentriq in mTNBC
Roche has voluntarily withdrawn its US accelerated approval for Tecentriq (atezolizumab) in combination with chemotherapy for the treatment of adults with unresectable locally advanced or meta...
Catalent to Extend Leadership in Rapidly Growing Nutraceuticals Market with Proposed $1 Billion Acquisition of Bettera, a Leading Gummies Manufacturer
Catalent to Extend Leadership in Rapidly Growing Nutraceuticals Market with Proposed $1 Billion Acquisition of Bettera, a Leading Gummies Manufacturer
SOMERSET, N.
RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant
RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant
TEL AVIV, Israel and RALEIGH, N.
Sesen Bio Pulls EU Application for Cancer Drug FDA Rejected
Sesen Bio Pulls EU Application for Cancer Drug FDA Rejected
Sesen Bio has withdrawn its EU marketing authorization application for Vysyneum (oportuzumab monatox-qqrs) ― called Vicineum in the U.
CellMax Life’s Cancer Blood Test Designated FDA Breakthrough Device
CellMax Life’s Cancer Blood Test Designated FDA Breakthrough Device
Molecular diagnostics company CellMax Life’s FirstSight pre-cancer and cancer detection blood test has received the FDA’s Breakthrough Device designation.
FDA approves MicroTransponder Vivistim Paired VNS System
FDA approves MicroTransponder Vivistim Paired VNS System
Vivistim is claimed to be the first-of-its-kind system to treat moderate to severe upper extremity motor deficits associated with chronic ischemic stroke using vagus nerve stimulationMicroTransponder ...
Sony's head of AI research wants to build robots that can win a Nobel Prize
Sony's head of AI research wants to build robots that can win a Nobel Prize
AI and Machine Learning systems have proven a boon to scientific research in a variety of academic fields in recent years.
EMA fast-tracks Marinus Pharma’s rare epilepsy treatment
EMA fast-tracks Marinus Pharma’s rare epilepsy treatment
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved Marinus Pharmaceuticals’ request for accelerated assessment of its lead p...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand